# New COVID Variant Emerges in 25 States; FDA Launches New Side-Effect Reporting System

Page: https://stenobird.com/podcast/facts-matter-4835545/new-covid-variant-emerges-in-25-states-fda-launches-new-side-effect-reporting-system
Text version: https://stenobird.com/podcast/facts-matter-4835545/new-covid-variant-emerges-in-25-states-fda-launches-new-side-effect-reporting-system.md
Podcast: [Facts Matter](https://stenobird.com/podcast/facts-matter-4835545)
Published: 2026-04-03T00:00:00+00:00
Episode link: https://www.theepochtimes.com/podcasts
Audio file: https://episodes.captivate.fm/episode/f0d15fd1-5bfa-4489-b407-87e96981ef2b.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/facts-matter-4835545/episodes/new-covid-variant-emerges-in-25-states-fda-launches-new-side-effect-reporting-system
Duration seconds: 534

## Resource

The Food and Drug Administration is combining seven of its side-effect reporting systems into one to save money and provide transparency to the public. Meanwhile, a new virus is spreading throughout the United States, masquerading as the flu. Lastly, a new strain of COVID has been detected in the United States, this time with many more mutations on the spike protein. Let's go through it all together.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/facts-matter-4835545/episodes/new-covid-variant-emerges-in-25-states-fda-launches-new-side-effect-reporting-system/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/facts-matter-4835545/new-covid-variant-emerges-in-25-states-fda-launches-new-side-effect-reporting-system.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.